Matinas Biopharma Plunges 14.83% After Warrant Exchange

On August 18, 2025, Matinas Biopharma's stock experienced a significant drop of 14.83% in pre-market trading, marking a notable decline in its share price.

Matinas Biopharma recently exchanged warrants for 466,666 shares of its common stock. This move involved canceling an equal number of warrants, each previously exercisable at $17.50 per share. The exchange was completed on August 15, 2025, and the warrants were issued on April 5, 2024. This action was done in reliance on an exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933.

Additionally, Matinas Biopharma Holdings Inc. performed a 1 for 50 consolidation. This means that holders of the company's stock will now hold 1 share for every 50 shares they previously owned. This consolidation is a corporate action that can impact the stock's liquidity and trading dynamics.